Pregled bibliografske jedinice broj: 1170210
Serologic infection testing of autologous blood donors
Serologic infection testing of autologous blood donors // XXIXth International Congress of the International Society of Blood Transfusion
Cape Town, Južnoafrička Republika, 2006. str. 233-233 (poster, podatak o recenziji nije dostupan, sažetak, ostalo)
CROSBI ID: 1170210 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Serologic infection testing of autologous blood
donors
Autori
Lukić, Marija ; Golubić Ćepulić, Branka ; Bojanić, Ines ; Plenković, Fini ; Mazić, Sanja ; Ivanković, Zdravko ; Tripković, Branko ; Melita, Š ; Koržinek, Krešimir ; Orlić, Dubravko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Skup
XXIXth International Congress of the International Society of Blood Transfusion
Mjesto i datum
Cape Town, Južnoafrička Republika, 2.-7.9
Vrsta sudjelovanja
Poster
Vrsta recenzije
Podatak o recenziji nije dostupan
Ključne riječi
serologic infection testing, autologous blood donors
Sažetak
Background:Inadvertent homologous transfusion of autologous bloodmay cause serious blood-borne infections in the recipient, dependingof donor status. Aims:We analysed the incidence of blood- borne infections in autolo-gous blood donors. Methods:We tested 2843 autologous blood donors for HbsAg, anti-HCV, anti-HIV and antibodies to Treponema pallidum (TP) between 2000-2005. Standard of confirmation tests were performed for all reactive tests. Results:Total of 60 (2, 11%) autologous blood donors were initiallyreactive for at least one of the markers. Confirmed tests were positivein 55/2843 (1, 93%) patients: HbsAg in 21 (0, 74%) cases, anti-HCV 22(0, 77%) cases, and anti-TP 12 (0, 42%) cases, but no case of positiveanti-HIV was found. Initially reactive, but later confirmed as negative, were one anti-HIV and 4 anti-TP positive cases. The overall frequen- cy of confirmed HBsAg, anti-HCV, anti-HIV and anti-TP was 1, 93 %in all autologous donors. Nine of 22 (40, 9%) anti-HCV positivepatients was transfused with homologous blood before 1993, whenanti-HCV testing become obligated in Croatia, and 14/22 (63, 6%)patients with positive anti-HCV was older than 65 years. Conclusions:Our data show that procedures to minimise the risk ofinadvertent homologous transfusion of autologous blood are neces- sary in spite of the implementation of screening tests in autologousdonation programs.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Klinički bolnički centar Zagreb
Profili:
Branka Golubić Ćepulić
(autor)
Dubravko Orlić
(autor)
Krešimir Koržinek
(autor)
Melita Švob
(autor)
Sanja Mazić
(autor)
Fini Plenković
(autor)
Marija Lukić
(autor)
Zdravko Ivanković
(autor)
Branko Tripković
(autor)
Ines Bojanić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE